SCHEMBL23881797

SCHEMBL23881797

O=C(CCC(NC(=O)OCc1ccccc1)P(=O)(O)CCc1cccc(Cl)c1)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ PTPN7 P35236 1/20 0.46
▸ OPRD1 P41143 1/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ECE1 P42892 7/20 0.44
▸ MME P08473 6/20 0.44
▸ ACE2 Q9BYF1 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ KLK8 O60259 1/20 0.42
▸ F2 P00734 1/20 0.42
▸ PLG P00747 1/20 0.42
▸ PLAU P00749 1/20 0.42
▸ PLAT P00750 1/20 0.42
▸ KLK1 P06870 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23881778 0.93 MME (0.52) MEN1LMNAMAPTALOX12PTPN7
SCHEMBL23881665 0.90 ECE1 (0.50) ECE1MMEACE2KLK8F2
SCHEMBL23881707 0.88 MEN1 (0.46) MEN1LMNAMAPTHTTKMT2A
SCHEMBL23881899 0.86 NPC1 (0.46) ECE1MMEACE2KLK8F2
SCHEMBL23881675 0.86 CASP1 (0.56) ECE1MMEACE2KLK8F2
SCHEMBL23881706 0.85 TGM2 (0.45) MEN1MAPTHTTKMT2AECE1
SCHEMBL23881768 0.85 ECE1 (0.45) MEN1LMNAMAPTPTPN7OPRK1
SCHEMBL23881686 0.84 ECE1 (0.43) MEN1LMNAMAPTPTPN7OPRK1
SCHEMBL23881738 0.84 CASP1 (0.51) ECE1MMEACE2KLK8F2
SCHEMBL23881850 0.83 ACE2 (0.50) ECE1MMEACE2KLK8F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192907-B2 Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same QUANTUM GENOMICS (FR) 2021-12-07 — — US disclosed
US-20210309678-A1 AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Institut National de la Santé et de la Recherche Médicale (FR) 2021-10-07 — — US disclosed
CN-113166182-A Aminopeptidase A inhibitor and pharmaceutical composition comprising the same 量子基因公司 2021-07-23 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192907-B2 Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same ANPEP, DNPEP, ENPEP MEN1 1271/4885LMNA 969/4885MAPT 1722/4885
US-20210309678-A1 AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME ANPEP, DNPEP, ENPEP MEN1 1271/4885LMNA 969/4885MAPT 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback